Immunogenic superiority and safety of Biological E CORBEVAX vaccine compared to COVISHIELD (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial

Subhash Thuluva; Vikram Paradkar; Kishore Turaga; Subbareddy Gunneri; Vijay Yerroju; Rammohan Reddy Mogulla; Venkata Suneetha Pothakamuri; Mahesh Kyasani; Senthilkumar Manoharan; Srikanth Adabala; Aditya Sri Javvadi; Guruprasad R Medigeshi; Janmejay Singh; Heena Shaman; Akshay Binayke; Aymaan Zaheer; Amit Awasrhi; Chandramani Singh; Venkateshwar Rao A; Indranil Basu; Akash Ashok Kumar Khobragade; Anil Kumar Pandey

bioRxiv (2022) - Comments
doi: 10.1101/2022.03.20.22271891

Subhash Thuluva, Vikram Paradkar, Kishore Turaga, Subbareddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Venkata Suneetha Pothakamuri, Mahesh Kyasani, Senthilkumar Manoharan, Srikanth Adabala, Aditya Sri Javvadi, Guruprasad R Medigeshi, Janmejay Singh, Heena Shaman, Akshay Binayke, Aymaan Zaheer, Amit Awasrhi, Chandramani Singh, Venkateshwar Rao A, Indranil Basu